Medication Treatments | Addiction Professional Magazine Skip to content Skip to navigation

Medication Treatments

Place medication in the rightful context

June 27, 2017  |  Gary A. Enos, Editor
A number of experts in the addiction field would like to see use of the term "medication-assisted treatment" eradicated, saying that it perpetuates stigma.

Patients benefit from having voice in treatment planning

June 26, 2017  |  Tom Valentino, Senior Editor
Engaging clients in dialogue during treatment planning and implementation can improve the odds of better outcomes, Robert Matylewicz, DO, FASAM, medical director at Clarity Way Inc., told attendees of the Summit for Clinical Excellence event Monday in...

Few young people with opioid dependence have received medication

June 21, 2017  |  Gary A. Enos, Editor
A Boston Medical Center study has found that just over one-quarter of adolescents and young adults diagnosed with an opioid use disorder from 2001-2014 received a prescription for buprenorphine or naltrexone.

AATOD leader among Faces & Voices honorees

June 20, 2017  |  Gary A. Enos, Editor
Mark Parrino of the American Association for the Treatment of Opioid Dependence (AATOD) will receive the Lisa Mojer-Torres Award next month from Faces & Voices of Recovery.

Research will apply technology to improve buprenorphine compliance

June 20, 2017  |  Gary A. Enos, Editor
The National Institute on Drug Abuse (NIDA) is funding a study that will determine whether direct observation of patients receiving buprenorphine treatment can improve retention in treatment and drug use outcomes.

NIH, private partners team up on opioid crisis initiative

June 19, 2017  |  Tom Valentino, Senior Editor
The National Institutes of Health (NIH) has announced a partnership with private entities on a three-faceted scientific initiative to address the opioid crisis.

Faces & Voices will honor researcher Kreek

June 15, 2017  |  Gary A. Enos, Editor
Mary Jeanne Kreek, MD, whose research helped lead to the development of methadone maintenance treatment, will receive a lifetime achievement award from Faces & Voices of Recovery next month.

Predictive testing company under fraud investigation

June 12, 2017  |  Gary A. Enos, Editor
Proove Biosciences, which markets technology designed to predict a patient's response to opioid dependence medications and other drugs, has had its office headquarters raided in an apparent healthcare fraud probe.

SAMHSA: Medication treatment for SUD increases significantly

June 12, 2017  |  Julie Miller, Editor in Chief
According to SAMHSA’s latest Behavioral Health Barometer, between 2011 and 2015, methadone use increased by 16%, and use of buprenorphine more than doubled.

New approach to drug development could give rise to cocaine treatment

June 8, 2017  |  Gary A. Enos, Editor
A final approved product is still years away, but ongoing research exploring the link between stress and addiction could result in a long-awaited medication treatment for cocaine dependence.

Baltimore ushers in easier public access to naloxone

June 2, 2017  |  Gary A. Enos, Editor
A new standing order from Baltimore Health Commissioner Leana Wen, following the lead of newly adopted legislation, essentially results in over-the-counter access to the opioid overdose reversal drug.

PCSS-MAT offers training for NPs, PAs to obtain buprenorphine prescribing waiver

May 30, 2017  |  Tom Valentino, Senior Editor
Providers’ Clinical Support System for Medication Assisted Treatment has developed a 24-hour course for nurse practitioners and physician assistants to treat opioid use disorder.


Subscribe to Medication Treatments